"Trade Talks Should Address Rising US Drug Costs, Mount Sinai CEO Says" - Alia Paavola
According to Kenneth Davis, MD, president and CEO of the Mount Sinai Health System, the Trump administration should make the rising costs of prescription drugs a top issue to address in trade talks with other countries. Dr. Davis added, “Why don’t we say, you guys can't allow the U.S. consumer to be subsidizing all the research and development costs of drug development. You've got to pay your fair share. We want to see you add 20 percent to the cost of your drugs.” Combating the rising costs of drugs in the U.S. is a bipartisan issue, and many lawmakers are working on proposals to help bring costs down.
— Kenneth L. Davis, MD, President, CEO, Mount Sinai Health System